Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

2007 ◽  
Vol 13 (9) ◽  
pp. 1102-1107 ◽  
Author(s):  
Sandeep T Patil ◽  
Lu Zhang ◽  
Ferenc Martenyi ◽  
Stephen L Lowe ◽  
Kimberley A Jackson ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 2 ◽  
New Approach ◽  
Phase 2 Clinical Trial ◽  
Randomized Phase 2

scholarly journals Erratum: Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

2007 ◽  
Vol 13 (10) ◽  
pp. 1264-1264 ◽  
Author(s):  
Sandeep T Patil ◽  
Lu Zhang ◽  
Ferenc Martenyi ◽  
Stephen L Lowe ◽  
Kimberley A Jackson ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 2 ◽  
New Approach ◽  
Phase 2 Clinical Trial ◽  
Randomized Phase 2

Tolerability and Efficacy of N-Chlorotaurine in Epidemic Keratoconjunctivitis—a Double-Blind, Randomized, Phase-2 Clinical Trial

2005 ◽  
Vol 21 (2) ◽  
pp. 157-165 ◽  
Author(s):  
Barbara Teuchner ◽  
Markus Nagl ◽  
Axel Schidlbauer ◽  
Hiroaki Ishiko ◽  
Ernst Dragosits ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 2 ◽  
Epidemic Keratoconjunctivitis ◽  
Double Blind ◽  
Phase 2 Clinical Trial ◽  
Randomized Phase 2

A randomized, phase 2 clinical trial of lithium carbonate in Machado-Joseph disease

2014 ◽  
Vol 29 (4) ◽  
pp. 568-573 ◽  
Author(s):  
Jonas Alex Morales Saute ◽  
Raphael Machado de Castilhos ◽  
Thais Lampert Monte ◽  
Artur Francisco Schumacher-Schuh ◽  
Karina Carvalho Donis ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Lithium Carbonate ◽  
Phase 2 ◽  
Phase 2 Clinical Trial ◽  
Machado Joseph Disease ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document